Characterization of virus binding by neutralizing antibodies is important both in
understanding early events in viral infectivity and in development of vaccines. Neutralizing …

A panel of monoclonal antibodies (MAbs) which neutralize human papillomavirus type 11
(HPV11) in the athymic mouse xenograph neutralization assay and bind HPV11 virus-like …

The majority of the neutralizing epitopes of papillomaviruses (PV) are conformation-specific
and have not been fully characterised. Studies have, to date, been limited to a few HPV …

We have determined that three type-specific and conformationally dependent monoclonal
antibodies, H16. E70, H16. U4, and H16. V5, neutralize pseudotype human papillomavirus …

We have mapped the binding sites on human papillomavirus (HPV) type 6 for three HPV 6-
specific neutralizing monoclonal antibodies (mAbs). The critical binding residues were first …

Antibodies reactive to HPV types 6 and 11 were tested in ELISA and HPV-11 neutralization
assays to determine whether these closely related types shared cross-reactive neutralizing …

Studies of virus neutralization by antibody are a prerequisite for development of a
prophylactic vaccine strategy against human papillomaviruses (HPVs). Using HPV16 and-6 …

Although epitope mapping has identified residues on the human papillomavirus (HPV)
major capsid protein (L1) that are important for binding mouse monoclonal antibodies …

We have identified regions of the major capsid protein, L1, of the human papillomavirus
(HPV) type 16 (HPV-16 L1), that are recognized by five monoclonal antibodies (MAbs) …

Persistent infection with human papillomavirus type 16 (HPV-16) is strongly associated with
the development of cervical cancer. Neutralizing epitopes present on the major coat protein …